Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection.
about
T helper cell activation and human retroviral pathogenesisMonoclonal antibodies targeting CD38 in hematological malignancies and beyondMechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infectionNormal human pregnancy results in maternal immune activation in the periphery and at the uteroplacental interface.Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesisPeripheral neuropathy in primary HIV infection associates with systemic and central nervous system immune activation.Standardizing immunophenotyping for the Human Immunology Project.In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis.T lymphocytes from chagasic patients are activated but lack proliferative capacity and down-regulate CD28 and CD3ζ.High-dose vitamin D3 supplementation in children and young adults with HIV: a randomized, placebo-controlled trial.Interlaboratory variability of CD8 subset measurements by flow cytometry and its applications to multicenter clinical trials. NAID/NICHD Women and Infants Transmission Study GroupLymphocyte subpopulation reference ranges for monitoring human immunodeficiency virus-infected Chinese adults.Immune activation is associated with increased gut microbial translocation in treatment-naive, HIV-infected children in a resource-limited settingIn vitro influence of Mycoplasma penetrans on activation of peripheral T lymphocytes from healthy donors or human immunodeficiency virus-infected individualsLower Pre-Treatment T Cell Activation in Early- and Late-Onset Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cThe presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity.Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients.HIV-induced immune activation: pathogenesis and clinical relevance - summary of a workshop organized by the German AIDS Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks.Antibody microarray analysis of cell surface antigens on CD4+ and CD8+ T cells from HIV+ individuals correlates with disease stagesChronic alcohol increases CD8+ T-cell immunosenescence in simian immunodeficiency virus-infected rhesus macaques.Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functionsSignificant enlargement of a specific subset of CD3+CD8+ peripheral blood leukocytes mediating cytotoxic T-lymphocyte activity during human immunodeficiency virus infection.Flow cytometric characterizations of leukocyte subpopulations in the peripheral blood of northern pig-tailed macaques (Macaca leonina).The CD8+ HLA-DR+ T cells expanded in HIV-1 infection are qualitatively identical to those from healthy controlsChanges in peripheral blood lymphocytes in polycythemia vera and essential thrombocythemia patients treated with pegylated-interferon alpha and correlation with JAK2V617F allelic burden.Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells.HIV type 1 viremia on ART is positively associated with polyclonal T cell proliferation in subjects with T cell IFN-gamma secretion levels comparable to those of uninfected subjectsImprovements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy.T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB).Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma.Superantigen activation of CD4+ and CD8+T cells from HIV-infected subjects: role of costimulatory molecules and antigen-presenting cells (APC)Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease.Virus load correlates inversely with the expression of cytotoxic T lymphocyte activation markers in HIV-1-infected/AIDS patients showing MHC-unrestricted CTL-mediated lysis.Role of CD8(+) T cells in triggering reversal reaction in HIV/leprosy patients.HIV and Age Do Not Synergistically Affect Age-Related T cell Markers.HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral Therapy.
P2860
Q24650854-E8407F06-A22A-4627-8351-1034D883D389Q26766718-47641057-7C7B-45A2-91C8-369A9DB5B51DQ28081838-17E8CAFB-9CAC-4AC5-84A0-F1E91B613D2EQ33638166-D5ACBEE5-B60A-494F-9273-A9284BECF3FCQ34010283-0F342BD8-6F16-40A9-9D02-2DC833694A36Q34099733-F481B956-A33E-44C5-B8D0-4A988C395800Q34255224-AC1BC22C-1E48-4E3E-9A3B-96F8FEB043EEQ34387944-0AEF4667-4D36-4C93-AC02-034D2AB34E47Q34412603-987A3E50-595A-4D4C-AE36-A42DE120129FQ34577261-ACC69421-957F-4FD1-A815-87617E4E344EQ34799320-625DB870-444F-44E3-A977-956BCD79EDA0Q35224739-E119CD01-4DC5-4DB6-95EE-9DE9817B3884Q35226862-70D6BF50-D5CA-4C49-B494-54A4F7AA33D4Q35283132-74596365-43CE-427E-8511-C7F410C5CDD4Q35448483-F78B7420-2AF9-47D8-82D3-1A2FF43D23B8Q35711609-2DB22981-60AA-4D89-BD56-1A2EEE228FBFQ35749755-6B31C206-38AD-44BC-AEED-FC096C430732Q35785054-0CD200B9-DB22-424F-B3DF-D02FFF196622Q35877952-DE34AFB2-8964-4DD3-A7A6-4E92EA21F780Q35935297-D64BB650-C9C3-4320-8DC8-3EFD8405C59BQ35958548-F3B2539E-AAA8-488B-A459-42B6FF7AED04Q36250357-E4D29C19-B339-4BA7-8334-1445B9459C11Q36402115-9DB52D26-E3E8-4D4A-AEAB-63F96AFB70E6Q36404961-A9311335-24DC-4568-97B1-5F974DC963D5Q36585656-EF261C52-6B04-46CE-A6EC-A63ACB94EB71Q36592108-D0E8742F-86AB-427F-A26D-8B864CF2347CQ36683444-FFB962D6-0148-4D2A-BED0-48B8C55DEEB3Q37281287-A68EF546-FC78-447B-B114-D78CF143D7C8Q37286731-14BB738E-188C-4623-A3D3-83895470350EQ37328900-6186D29C-0412-44BD-841B-CD42A0F3E96BQ37388340-DF830DCF-3542-467B-91AA-6E04049B59CEQ37417396-A1DECD8D-0808-484D-8ACE-34A49C805E78Q38885631-34602511-0806-4A0D-BBCE-A677C531EC86Q39489706-121BB567-ECCF-455E-AA72-E3B7CA2552BFQ39561905-DA2B6872-5031-47A1-B2AE-4528C3011712Q39822623-B4AC4C80-8583-4DB3-B886-4A08E84B2E12Q45728636-B2156D6E-72CA-416A-ACE3-2A27DC4E8EBEQ45984080-B8A246AA-1351-435B-8419-AC129A9F13F4Q46042029-DA5786E8-3049-4123-8E8E-86B26B66FDE5Q46224865-7C6B70F9-DC6E-4F9A-A87C-2C75DF4F3909
P2860
Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Expression of activation antig ...... ocytes during HIV-1 infection.
@en
Expression of activation antig ...... ocytes during HIV-1 infection.
@nl
type
label
Expression of activation antig ...... ocytes during HIV-1 infection.
@en
Expression of activation antig ...... ocytes during HIV-1 infection.
@nl
prefLabel
Expression of activation antig ...... ocytes during HIV-1 infection.
@en
Expression of activation antig ...... ocytes during HIV-1 infection.
@nl
P2093
P1433
P1476
Expression of activation antig ...... ocytes during HIV-1 infection.
@en
P2093
Hulstaert F
Vanlangendonck F
P304
P407
P577
1992-08-01T00:00:00Z